SARS-CoV-2 & Influenza A/B Combo Antigen Rapid Test
-
System Device for SARS-CoV-2 & Influenza A/B Combo Antigen Rapid Test
REF 500220 Specification 20 Tests/Box Detection principle Immunochromatographic assay Specimens Nasal / Oropharyngeal swab Intended Use This is a rapid immunochromatographic assay for the detection of SARS-CoV-2 virus Nucleocapsid Protein antigen in human Nasal/Oropharyngeal swab collected from individuals who are suspected of COVID-19 by their healthcare provider within the first five days of the onset of symptoms. The assay is used as an aid in the diagnosis of COVID-19.